Abstract
Inflammation, a crucial defense mechanism, must be rigorously regulated to prevent the onset of chronic inflammation and subsequent tissue damage. Specialized pro resolving mediators (SPMs) such as lipoxin A4 (LXA4) have demonstrated their ability to facilitate the resolution of inflammation by orchestrating a transition of M1 pro-inflammatory macrophages towards an anti-inflammatory M2 phenotype. However, the hydrophobic and chemically labile nature of LXA4 necessitates the development of a delivery system capable of preserving its integrity for clinical applications. In this study, two types of emulsion were formulated using different homogenization processes:mechanical overhead stirrer (MEB for blank Emulsion and MELX for LXA4 loaded-Emulsion) or Luer-lock syringes (SEB for blank Emulsion and SELX for LXA4 loaded-Emulsion)). Following characterization, including size and droplet morphology assessment by microscopy, the encapsulation efficiency (EE) was determined using liquid chromatography-tandem mass spectrometry (LC-MS/MS). To exert control over LXA4 release, these emulsions were embedded within silanized hyaluronic acid hydrogels. A comprehensive evaluation, encompassing gel time, swelling, and degradation profiles under acidic, basic, and neutral conditions, preceded the assessment of LXA4 cumulative release using LC-MS/MS. Physicochemical results indicate that H-MELX (Mechanical overhead stirrer LXA4 Emulsion loaded-Hydrogel) exhibits superior efficiency over H-SELX (Luer-lock syringes LXA4 Emulsion loaded-Hydrogel). While both formulations stimulated pro-inflammatory cytokine secretion and promoted a pro-inflammatory macrophage phenotype, LXA4 emulsion-loaded hydrogels displayed a diminished pro-inflammatory activity compared to blank emulsion-loaded hydrogels. These findings highlight the biological efficacy of LXA4 within both systems, with H-SELX outperforming H-MELX in terms of efficiency. To the best of our knowledge, this is the first successful demonstration of the biological efficacy of LXA4 emulsion-loaded hydrogel systems on macrophage polarization. These versatile H-MELX and H-SELX formulations can be customized to enhance their biological activity making them promising tools to promote the resolution of inflammation in diverse clinical applications.
Graphical Abstract
Similar content being viewed by others
Data availability statement
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- DMTMM:
-
4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride
- EE:
-
Encapsulation Efficiency
- FBS:
-
Fetal Bovine Serum
- H-MEB:
-
Mechanical overhead stirrer Blank Emulsion loaded Hydrogel
- H-MELX:
-
Mechanical overhead stirrer LXA4 Emulsion loaded-Hydrogel
- H-SEB:
-
Luer-lock syringes Blank Emulsion loaded-Hydrogel
- H-SELX:
-
Luer-lock syringes LXA4 Emulsion loaded Hydrogel
- HA:
-
Hyaluronic Acid
- HPMC:
-
Hydroxypropylmethylcellulose
- IL-1β:
-
Interleukin-1β
- IL-1RA:
-
Interleukin-1 Receptor Antagonist
- IL-4:
-
Interleukin-4
- IL-6:
-
Interleukin-6
- IL-10:
-
Interleukin-10
- IL-12p40:
-
Interleukin-12p40
- IL-12p70:
-
Interleukin-12p70
- IL-13:
-
Interleukin-13
- IL-23:
-
Interleukin-23
- IP-10:
-
Interferon-gamma-induced Protein-10
- LC-MS/MS:
-
Liquid chromatography-tandem mass spectrometry
- LPS:
-
Lipopolysaccharide
- LXA4:
-
Lipoxin A4
- MEB:
-
Mechanical overhead stirrer Blank Emulsion
- MELX:
-
Mechanical overhead stirrer LXA4 loaded-Emulsion
- MMP:
-
Matrix MetalloProteinases
- MES:
-
2-(N-morpholino)ethanesulfonic acid
- RPMI:
-
Roswell Park Memorial Institute
- ROS:
-
Reactive Oxygen Species
- SEB:
-
Luer-lock syringes Emulsion Blank
- SELX:
-
Luer-lock syringes LXA4 loaded-Emulsion
- SPM:
-
Specialized Pro resolving Mediators
- TARC:
-
Thymus and Activation Regulated Cytokine
- TNF-α:
-
Tumor Necrosis Factor-α
- UPLC/MS:
-
Ultra-Performance Liquid Chromatography and Tandem Mass Spectrometry
References
Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol. 2000;2013(63):149–64.
Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92–101.
Serhan CN. Treating inflammation and infection in the 21st century: New hints from decoding resolution mediators and mechanisms. FASEB J. 2017;31:1273–88.
Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity. 2014;40:315–27.
Yuan J, Lin F, Chen L, et al. Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2-IRF pathway. Inflammopharmacology. 2022;30:487–98.
Aubeux D, Tessier S, Pérez F, et al. In vitro phenotypic effects of Lipoxin A4 on M1 and M2 polarized macrophages derived from THP-1. Mol Biol Rep. 2023;50:339–48.
Karra L, Haworth O, Priluck R, et al. Lipoxin B4 promotes the resolution of allergic inflammation in the upper and lower airways of mice. Mucosal Immunol. 2015;8:852–62.
Dakin SG, Martinez FO, Yapp C, et al. Inflammation activation and resolution in human tendon disease. Sci Transl Med. 2015;7:311ra173-311ra173.
Hu S, Mao-Ying Q-L, Wang J, et al. Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines. J Neuroinflammation. 2012;9:278.
Serna MF, Mosquera Escudero M, García-Perdomo HA. Lipoxins and their relationship with inflammation-associated diseases. A systematic review. Obes Res Clin Pract. 2023;17:298–307.
De Gaetano M, Butler E, Gahan K, et al. Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms). Eur J Med Chem. 2021;162:80–108.
Dhaval M, Vaghela P, Patel K, et al. Lipid-based emulsion drug delivery systems - a comprehensive review. Drug Deliv Transl Res. 2022;12:1616–39.
Milutinov J, Krstonošić V, Ćirin D, Pavlović N. Emulgels: Promising carrier systems for food ingredients and drugs. Polymers (Basel). 2023;15(10):2302. https://doi.org/10.3390/polym15102302. PMID: 37242878; PMCID: PMC10223308.
Flegeau K, Toquet C, Rethore G, et al. In situ forming, silanized hyaluronic acid hydrogels with fine control over mechanical properties and in vivo degradation for tissue engineering applications. Adv Healthc Mater. 2020;9: e2000981.
Lund ME, To J, O’Brien BA, et al. The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus. J Immunol Methods. 2016;430:64–70.
Wijayaratna U, Kiridena S, Adams JD, Behrend CJ, Anker JN. Synovial fluid pH sensor for early detection of prosthetic hip infections. Adv Funct Mater. 2021;31(37):2104124. https://doi.org/10.1002/adfm.202104124. Epub 2021 Jun 26. PMID: 36478668; PMCID: PMC9725744.
Marunaka Y. Roles of interstitial fluid pH in diabetes mellitus: Glycolysis and mitochondrial function. World J Diabetes. 2015;6:125–35.
Galgut PN. The relevance of pH to gingivitis and periodontitis. J Int Acad Periodontol. 2001;3:61–7.
Wang B, Shao J, Jansen JA, et al. A novel thermoresponsive gel as a potential delivery system for lipoxin. J Dent Res. 2019;98:355–62.
Lynch KL. CLSI C62-A: A New Standard for Clinical Mass Spectrometry. Clin Chem. 2016;62:24–9.
Thomas SN, French D, Jannetto PJ, et al. Liquid chromatography–tandem mass spectrometry for clinical diagnostics. Nat Rev Methods Prim. 2022;2:96.
Hartling I, Cremonesi A, Osuna E, et al. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS. Clin Chem Lab Med. 2021;59:1811–23.
Tan MXL, Danquah MK. Drug and protein encapsulation by emulsification: technology enhancement using foam formulations. Chem Eng Technol. 2012;35:618–26.
Tonon RV, Grosso CR, Hubinger MD. Influence of emulsion composition and inlet air temperature on the microencapsulation of flaxseed oil by spray drying. Food Res Int. 2011;44:282–9.
Luo Z, Wang Y, Xu Y, et al. Modification and crosslinking strategies for hyaluronic acid-based hydrogel biomaterials. Smart Med. 2023;2:1–18.
Zeng L, Zhang Y. Impact of short-chain alcohols on the formation and stability of nano-emulsions prepared by the spontaneous emulsification method. Colloids Surfaces A Physicochem Eng Asp. 2016;509:591–600.
Lin C-C, Metters AT. Hydrogels in controlled release formulations: network design and mathematical modeling. Adv Drug Deliv Rev. 2006;58:1379–408.
Kadomoto S, Izumi K, Mizokami A. Macrophage polarity and disease control. Int J Mol Sci. 2021;23(1):144. https://doi.org/10.3390/ijms23010144. PMID: 35008577; PMCID: PMC8745226.
Fontana F, Cafarelli A, Iacoponi F, et al. Pulsed electromagnetic field stimulation enhances neurite outgrowth in neural cells and modulates inflammation in macrophages. Eng Regen. 2024;5:80–91.
Clish CB, Levy BD, Chiang N, et al. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. J Biol Chem. 2000;275:25372–80.
Gaudin A, Tolar M, Peters OA. Lipoxin A4 attenuates the inflammatory response in stem cells of the apical papilla via ALX/FPR2. Sci Rep. 2018;8:1–12.
Inyang E, Abhyankar V, Chen B, et al. Modulation of in vitro Brain Endothelium by Mechanical Trauma: Structural and Functional Restoration by Poloxamer 188. Sci Rep. 2020;10:3054.
Linke A, Linke T, Hinrichs J, et al. Factors determining the surface oil concentration of encapsulated lipid particles—impact of the spray drying conditions. Dry Technol. 2019;39:173–86.
Li X, Li X, Yang J, Du Y, Chen L, Zhao G, Ye T, Zhu Y, Xu X, Deng L, Cui W. In situ sustained macrophage-targeted nanomicelle-hydrogel microspheres for inhibiting osteoarthritis. Research (Wash D C). 2023;6:0131. https://doi.org/10.34133/research.0131. PMID: 37223475; PMCID: PMC10202383.
Acknowledgements
The authors are grateful to the Plateforme Spectrométrie de masse (PFSM) – and the cytometry Facility “Cytocell” facilities for expert technical assistance. The authors gratefully acknowledge Christine Herrenknecht (laboratoire Mer Molécules Santé (MMS)) for her technical help.
Funding
This work was supported by Agence Nationale de la Recherche (ANR) for funding the project Grant numbers JCJC BILIPOX (ANR-19-CE19-0006).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Léna Guyon, Solène Tessier, Mikaël Croyal, Mathilde Gourdel, Marianne Lafont, Florian Segeron, Lionel Chabaud, Hélène Gautier, Pierre Weiss, Alexis Gaudin. The first draft of the manuscript was written by Léna Guyon, Solène Tessier and Alexis Gaudin and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
N/A.
Consent for publication
N/A.
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Guyon, L., Tessier, S., Croyal, M. et al. Influence of physico-chemical properties of two lipoxin emulsion-loaded hydrogels on pre-polarized macrophages: a comparative analysis. Drug Deliv. and Transl. Res. (2024). https://doi.org/10.1007/s13346-024-01588-9
Accepted:
Published:
DOI: https://doi.org/10.1007/s13346-024-01588-9